{"id":328115,"date":"2026-10-27T12:08:25","date_gmt":"2026-10-27T06:38:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=328115"},"modified":"2026-10-27T12:08:25","modified_gmt":"2026-10-27T06:38:25","slug":"branded-generics-marketer-anti-infectives-and-gastro-leader-and-custom-synthesis-ingredients-leader-stocks-roadmap-zenith-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/branded-generics-marketer-anti-infectives-and-gastro-leader-and-custom-synthesis-ingredients-leader-stocks-roadmap-zenith-list\/","title":{"rendered":"3 Branded Generics Marketer, Anti-Infectives and Gastro Leader and Custom Synthesis Ingredients Leader Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Alkem Laboratories and Divi’s Laboratories"},"content":{"rendered":"

Emcure Pharmaceuticals, Alkem Laboratories and Divi’s Laboratories: ROE of 15.3% to 18.7% and FY22 to FY26 revenue CAGR of 5.1% to 12.1%. Prices as of 26 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three branded generics, acute care and API stocks to watch are Emcure Pharmaceuticals, Alkem Laboratories and Divi’s Laboratories. Their return on equity ranges from 15.3% to 18.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.1% to 12.1%. Emcure Pharmaceuticals leads on both return on equity at 18.7% and revenue growth at 12.1% a year. Prices are based on the 26 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Branded generics, acute care and API stocks give investors a way to track businesses that sit close to everyday demand in India. Emcure Pharmaceuticals, Alkem Laboratories and Divi’s Laboratories cover a branded generics marketer, an anti-infectives and gastro leader and a custom synthesis ingredients leader.<\/p>\n

This list covers three branded generics, acute care and API stocks with complete current figures: Emcure Pharmaceuticals, Alkem Laboratories and Divi’s Laboratories. Every figure comes from the latest reported financials and the 26 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n